Atopic Dermatitis Vaccine Study

Principle Investigator Petra Bizikova Description A new trial to investigate a novel monoclonal antibody drug. The goal is to greatly reduce or eliminate the symptoms of this condition thus improving the dog’s quality of life. Testing Requirements -Patients will be required to come to NCSU for 8 study visits over the course of 14 weeks.…

Dogs with Non-Seasonal Atopic Dermatitis

Principle Investigator Ina Herrmann Description This study is looking for dogs that have non-seasonal atopic dermatitis for a trial to investigate a novel injectable medication similar to Xolair®/Omalizumab with the potential to control the disease for weeks to months. The goal of this study is to reduce the need for daily medications and improving the…